Join us at Booth B25 to explore how our microfluidic picodroplet technology platforms can accelerate your workflows in drug discovery and development. Let’s discuss how we can streamline your processes, enhance efficiency, and drive groundbreaking advancements in therapeutic development.
Insights and Innovations
Join Jessica Hall for a Poster Showcase
Picodroplets for Biologics Discovery and Cell Line Development: Accelerating the Discovery and Development Process
Wed. 2 Oct (Day 1) at 17:00 – 17:30
during the networking session
Thurs. Oct 3 (Day 2) at 13:00 – 13:30
during the refreshment break
Exhibition Hall, poster area, poster #63
Jessica Hall, Senior Field Application Scientist, Sphere Fluidics
View our latest poster presentation featuring the next generation of Cyto-Mine®
Highlights Include:
Faster project completion
Multiplexing capabilities
Rapid identification and isolation of rare cells
Assurance of monoclonality in selected cells
POSTER DETAILS
Picodroplets for Biologics Discovery and Cell Line Development: Accelerating the Discovery and Development Process
Although antibody therapeutics dominate drug development, prolonged workflows and increasing costs during their discovery and development hinder their success. Cyto-Mine® by Sphere Fluidics, utilizes picodroplet technology, microfluidics and imaging, to address these obstacles in Antibody Discovery (AbD) and Cell Line Development (CLD), expediting therapeutic development.
Cyto-Mine® offers significant advantages in the number of cells that can be processed, cost per run, and the speed with which projects can be completed. Sphere Fluidics has developed a second generation Cyto-Mine® instrument that enables the use of more fluors, multiplexed assays, and a broader range of applications.
Early applications of the new Cyto-Mine® platform will enable cell isolation based on cell surface markers, viability, and titer of secreted proteins. Moreover, in combination with re-injection-based workflows, it will facilitate complex assays like combining cell types in a single droplet (crucial for binding assessment, cytotoxic assays, and advancing antibody development).
About Jessica Hall
Motivated to get you up and running with our products, and maintain Sphere Fluidics’ high standard of customer support, Jess is on hand to help you with your application needs. Having been on both sides of technical support as both an end-user and Field Application Scientist, she understands the necessity of having a friendly face at the end of a line for whom no request is too big nor too small.
Visit the Drug Discovery website to register now
We eagerly anticipate connecting with you at Drug Discovery 2024, a premier event for advancing the future of medicine. This event brings together industry and academic experts to exchange innovative ideas in various critical areas, including Antibody Discovery, Cell Engineering, Cell Line Development, Cell Therapy, and Synthetic Biology.
